Avalo Therapeutics (AVTX) Q3 2023 Earnings

Nov 9Confirmed
Nov 2022
Q4 2022
Q2 2023
Q3 2023
-1.1
-0.62
-0.14
0.34

Details

Expected EPS
-1.1
Actual EPS
-0.11
Surprise EPS
0.99
Surprise Percent
+90%

Description

⁨Avalo Therapeutics⁩ (⁦AVTX⁩) has reported earnings of ⁦-0.11⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts